Articles dans des revues avec comité de lecture (91)
  1. 75. Englert, Y., Van Den Bergh, M. J., Delbaere, A., Devreker, F., Koenig, I., Hannes, M., Emiliani, S., Biramane, J., Vannin, A.-S., Govaerts, I., Holoye, A., & Revelard, P. (1999). La fecondation in vitro a l'Hopital Erasme: 10 ans et 1000 grossesses plus tard.... Revue médicale de Bruxelles, 20(5), A436-A445.
  2. 76. Delbaere, A., Sidis, Y., & Schneyer, A. (1999). Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin. Endocrinology, 140(6), 2463-2470. doi:10.1210/endo.140.6.6824
  3. 77. Delbaere, A., Devreker, F., Hannes, M., Koenig, I., Holoye, A., & Englert, Y. (1999). Evolution de la stimulation ovarienne en fecondation in vitro. Revue médicale de Bruxelles, 20(5), A446-A452.
  4. 78. Englert, Y., Delbaere, A., Demeestere, I., Delneste, D., Devreker, F., Emiliani, S., Kennof, B., Laruelle, C., Place, I., & Ullman, U. (1999). Aspects de recherche scientifique et progres techniques en fertilite humaine. Revue médicale de Bruxelles, 20(5), A468-A476.
  5. 79. Delbaere, A., Devreker, F., Anagnostou, L., Emiliani, S., & Englert, Y. (1999). Extremely severe ovarian hyperstimulation syndrome despite withholding gonadotrophin administration during ovarian stimulation for IVF. Human reproduction, 14(1), 305.
  6. 80. Delbaere, A., & Englert, Y. (1999). Le syndrome d'hyperstimulation ovarienne. L'agenda gynécologie, 15, 8-9.
  7. 81. Govaerts, I., Devreker, F., Delbaere, A., Revelard, P., & Englert, Y. (1998). Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. European journal of obstetrics, gynecology, and reproductive biology, 77(2), 239-243. doi:10.1016/S0301-2115(97)00263-7
  8. 82. Delbaere, A., Gervy Decoster, C., Bergmann, P., Van Den Bergh, M. J., & Englert, Y. (1998). Follicular levels of active renin, prorenin and angiotensin II at the time of the oocyte pick-up in ICSI cycles. Human reproduction, 14(1), 128.
  9. 83. Delbaere, A., Bergmann, P., Gervy Decoster, C., Deschodt Lanckman, M., De Maertelaer, V., Staroukine, M., Camus, M., & Englert, Y. (1997). Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotrophin stimulation. Fertility and Sterility, 67(6), 1038-1045. doi:10.1016/S0015-0282(97)81436-7
  10. 84. Delbaere, A., Bergmann, P., & Englert, Y. (1997). Features of the renin-angiotensin system in ascites and pleural effusion during severe ovarian hyperstimulation syndrome. Journal of Assisted Reproduction and Genetics, 14(5), 241-244.
  11. 85. Delbaere, A., Bergmann, P., Gervy Decoster, C., De Maertelaer, V., Camus, M., & Englert, Y. (1997). Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Human Reproduction, 12(2), 236-240. doi:10.1093/humrep/12.2.236
  12. 86. Hollemaert, S., Wautrecht, J.-C., Capel, P., Abramowicz, M., Englert, Y., & Delbaere, A. (1996). Thrombosis associated with ovarian hyperstimulation syndrome in a carrier of the factor V Leiden mutation. Thrombosis and haemostasis, 76(2), 275-277.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Suivant >>